Clinical Trial Update: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib [Phase 3]

View source ↗

Summary

Phase 3 rollover study of Olaparib for patients who have completed a prior oncology trial is active but not recruiting. The trial is sponsored by AstraZeneca an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: AstraZeneca | Conditions: Ovarian Cancer, Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING